79854-42-5

Basic information

• Product Name: ETHYL INDOLINE-2-CARBOXYLATE
• Synonyms: ETHYL INDOLINE-2-CARBOXYLATE;ETHYL 2,3-DIHYDROINDOLE-2-CARBOXYLATE;Ethyl (S)-indoline-2-carboxylate hydrochloride, 98%;Ethyl 2-indolinecarboxylate
• CAS NO: 79854-42-5
• Molecular Formula: C₁₁H₁₃NO₂*ClH
• Molecular Weight: 191.23
• Mol File: 79854-42-5.mol
• Article Data: 20

Chemical Properties

• Melting Point: 55 °C
• Appearance: /
• Storage Temp.: Refrigerator
• CAS DataBase Reference: ETHYL INDOLINE-2-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL INDOLINE-2-CARBOXYLATE(79854-42-5)
• EPA Substance Registry System: ETHYL INDOLINE-2-CARBOXYLATE(79854-42-5)

Safety Data

• Hazard Codes: Xn
• Statements: 36/37/38-22
• Safety Statements: 26-36
• Hazardous Substances Data: 79854-42-5(Hazardous Substances Data)

Usage

Synthesis Reference(s)

Tetrahedron Letters, 27, p. 2409, 1986 DOI: 10.1016/S0040-4039(00)84542-6

Upstream product

• 64-17-5 ethanol 
• 79815-20-6 (S)-indoline-2-carboxylic acid 
• 10441-26-6 N-acetyl-indole-2-carboxylic acid 
• 103476-80-8 1-acetyl-2,3-indoline-2-carboxylic acid 
• 82923-75-9 N-acetyl-(S)-2,3-dihydro-1H-indole-2-carboxylic acid 
• 1477-50-5 Indole-2-carboxylic acid 
• 532970-59-5 (R)-indoline-2-carboxylic acid hydrochloride 
• 106517-51-5 indoline-2-carboxylic acid hydrochloride 
• 16851-56-2 indolin-2-yl carboxylic acid 
• 82950-72-9 1-acetyl-2,3-indoline-2-carboxylic acid 
• 82923-76-0 (S)-5-methoxyindol-2,3-dihydro-2-carboxylic acid hydrochloride 
• 763047-58-1 (S) indoline carboxylic acid 

Downstream Products

• 116587-00-9 (S)-1-[(R)-4-((S)-5-Amino-2-benzyloxycarbonylamino-pentanoylamino)-4-carboxy-butyryl]-2,3-dihydro-1H-indole-2-carboxylic acid 
• 127413-71-2 1-(N-benzyloxycarbonyl-L-phenylalanyl-γ-D-glutamyl)indoline-2(S)-carboxylic acid 
• 116586-99-3 1-(N²-benzyloxycarbonyl-L-lysyl-γ-D-glutamyl)indoline-2(S)-carboxylic acid 
• 127413-79-0 (S)-1-[(R)-4-((S)-2-Benzyloxycarbonylamino-3-phenyl-propionylamino)-4-ethoxycarbonyl-butyryl]-2,3-dihydro-1H-indole-2-carboxylic acid ethyl ester 
• 127413-70-1 (S)-1-[(R)-4-((S)-2-Benzyloxycarbonylamino-5-guanidino-pentanoylamino)-4-carboxy-butyryl]-2,3-dihydro-1H-indole-2-carboxylic acid 
• 116586-14-2 (S)-1-[(R)-4-((S)-2-Benzyloxycarbonylamino-6-tert-butoxycarbonylamino-hexanoylamino)-4-carboxy-butyryl]-2,3-dihydro-1H-indole-2-carboxylic acid 
• 116586-13-1 (S)-1-[(R)-4-((S)-2-Benzyloxycarbonylamino-6-tert-butoxycarbonylamino-hexanoylamino)-4-ethoxycarbonyl-butyryl]-2,3-dihydro-1H-indole-2-carboxylic acid ethyl ester 
• 117085-70-8 (S)-1-[(S)-6-Benzyloxycarbonylamino-2-(4-phenyl-butylphosphinoyloxy)-hexanoyl]-2,3-dihydro-1H-indole-2-carboxylic acid benzhydryl ester 
• 117085-67-3 *,R^*)>-2,3-dihydro-1-<2-<oxy>-1-oxo-6-<<(phenylmethoxy)carbonyl>amino>hexyl>-1H-indole-2-carboxylic acid diphenylmethyl ester 
• 117085-66-2 *,R^*)>-2,3-dihydro-1-<2-hydroxy-1-oxo-6-<<(phenylmethoxy)carbonyl>amino>hexyl>-1H-indole-2-carboxylic acid diphenylmethyl ester 
• 117085-60-6 *,R^*)>-2,3-dihydro-1-<6-amino-2-<oxy>-1-oxohexyl>-1H-indole-2-carboxylic acid 
• 145513-54-8 1-<(2S) 2-<((1S) 1-carbethoxybutyl) amino> 1-oxo propyl> (2S, 3aS, 7aS) perhydroindole 2-carboxylic acid 
• 107133-36-8 perindopril erbumine 
• 107045-53-4 (2S,3aS,7aS)-1-(benzyloxycarbonyl)octahydro-1H-indole-2-carboxylic acid 

Relevant articles and documents

Pyrrole compounds as granzyme B inhibitors

Pyrrole compounds as Granzyme B inhibitors, compositions that include the compounds, and methods for using the compounds. Method for treating cutaneous scleroderma, epidermolysis bullosa, radiation dermatitis, alopecia areata, and discoid lupus erythematosus are provided.

COSMETIC USES AND METHODS FOR INDOLINE GRANZYME B INHIBITOR COMPOSITIONS

Cosmetic uses and methods for indoline granzyme B inhibitor compounds in compositions with a cosmetically acceptable carrier. Uses and methods for treating, reducing or inhibiting the appearance of ageing in the skin are provided. Also provided are compositions and formulation for cosmetic uses and methods of maintaining a youthful appearance, reducing an appearance of ageing, inhibiting an appearance of ageing, reducing a rate of an appearance of ageing, reducing a skin inelasticity, reducing a rate of increasing skin inelasticity, maintaining a skin elasticity, and increasing the density of hair follicles of a skin of a subjecl. The uses and methods comprise applying/administering an indoline granzyme B inhibitor to a skin, or a portion of a skin of the subject.

TETRAPEPTIDE ANALOGS

Compounds, compositions and methods for treatment of hyperproliferative diseases, such as cancer are provided.